Literature DB >> 24938195

Pain in Sjögren's syndrome.

C Giacomelli1, R Talarico, C Baldini, L Bazzichi.   

Abstract

Sjögren's syndrome (SjS) is an autoimmune disease that affects the salivary and lacrimal glands, but it can also have extra-glandular manifestations. Although pain has not yet been fully studied and characterized, it is a symptom that can be often found in patients with SjS, who mainly complain of neuropathic pain, followed by nociceptive pain. The latter when combined with widespread dysfunctional symptoms is defined fibromyalgia. The aim of this work is to analyze the scientific literature on the presence of pain in patients with primary Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24938195     DOI: 10.4081/reumatismo.2014.763

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  3 in total

Review 1.  Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.

Authors:  Jonas Blomberg; Carl-Gerhard Gottfries; Amal Elfaitouri; Muhammad Rizwan; Anders Rosén
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

2.  Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome.

Authors:  Kate L Hackett; Kristen Davies; Jessica Tarn; Rebecca Bragg; Ben Hargreaves; Samira Miyamoto; Peter McMeekin; Sheryl Mitchell; Simon Bowman; Elizabeth J Price; Colin Pease; Paul Emery; Jacqueline Andrews; Peter Lanyon; John Hunter; Monica Gupta; Michele Bombardieri; Nurhan Sutcliffe; Costantino Pitzalis; John McLaren; Annie Cooper; Marian Regan; Ian Giles; David Isenberg; Saravan Vadivelu; David Coady; Bhaskar Dasgupta; Neil McHugh; Steven Young-Min; Robert Moots; Nagui Gendi; Mohammed Akil; Bridget Griffiths; Dennis W Lendrem; Wan-Fai Ng
Journal:  RMD Open       Date:  2019-04-24

3.  Identification of MOR-Positive B Cell as Possible Innovative Biomarker (Mu Lympho-Marker) for Chronic Pain Diagnosis in Patients with Fibromyalgia and Osteoarthritis Diseases.

Authors:  William Raffaeli; Valentina Malafoglia; Antonello Bonci; Michael Tenti; Sara Ilari; Paola Gremigni; Cristina Iannuccelli; Chiara Gioia; Manuela Di Franco; Vincenzo Mollace; Laura Vitiello; Carlo Tomino; Carolina Muscoli
Journal:  Int J Mol Sci       Date:  2020-02-22       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.